✦ LIBER ✦

Results of interferon alpha 2b (Introna) treatment in 22 patients with metastatic progressive differentiated endocrine tumors

✍ Scribed by C. Baiseau Corrieri; J.Y. Scoazec; O. Boillot; C. Dumanoir; C. Barel; J.C. Saurin; J. Dumortier; J.A. Chayvialle; C. Lombard-Bohas

Book ID: 117658259
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 167 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)80891-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination treatment of Sandostatin LAR

Combination treatment of Sandostatin LAR with human recombinant alpha interferon in patients with metastatic neuroendocrine tumors (NET)

✍ David Oh; Joseph Pisegna 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 25 KB

Interferon-α-2a with or without 13-cis r

Interferon-α-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma : Results of a randomized Phase II study (European Organization for Research and Treatment of Cancer Study 30951)

✍ Sophie D. Fosså; Gerald H. J. Mickisch; Pieter H. M. De Mulder; Simon Horenblas; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

## Background: In patients with metastatic renal cell carcinoma (mrcc), interferon-alpha (ifn) monotherapy leads to response rates of 5-15%, dependent on the selection of patients. in 1995, preclinical and clinical data indicated an improvement of these results if ifn was combined with 13-cis retin

Chemoimmunotherapy with dacarbazine, cis

Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: A randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group

✍ C.J.A. Punt; S. Suciu; M.A. Gore; J. Koller; W.H.J. Kruit; J. Thomas; P. Patel; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 150 KB